| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Unité Propre de Recherche de lEnseignement Supérieur EA220Pharmacology (C.R., M.B., H.Q., E.N., C.A.), Unité de Formation et de Recherche Biomédicale des Saints Pères, 75006 Paris, France; Institut National de la Santé et de la Recherche Médicale U427 (C.R., M.B.-F., H.Q., D.C., M.J.L.) and Department of Gynecology (D.C.), Port-Royal Maternity Hospital, 75014 Paris, France; Department of Gynecology (C.L.), Centre Hospitalier Universitaire du Bocage, 21000 Dijon, France; Sanofi-Aventis Research Center (T.C.), 20137 Milan, Italy; Laboratory of Cardiovascular Physiopathology and Pharmacology (M.B.), Faculty of Medicine, 21079 Dijon, France
Address all correspondence and requests for reprints to: Céline Rouget, Unité Propre de Recherche de lEnseignement Supérieur EA220Pharmacology, Unité de Formation et de Recherche Biomédicale des Saints Pères, 45 rue des Saints Pères, F-75006 Paris, France. E-mail: celine.rouget{at}univ-paris5.fr.
To assess whether pregnancy might influence the functionality and expression of human myometrial ß2- and ß3-adrenoceptors (ß2- and ß3-AR), we performed functional, binding, Western blot, and molecular biology experiments in human nonpregnant and near-term pregnant myometrium. Inhibition of spontaneous contractions induced by a ß3-AR agonist, SR 59119A, was significantly greater in pregnant, compared with nonpregnant, myometrial strips (E'max = 61 ± 5% vs. 44 ± 5% for pregnant and nonpregnant myometrium, respectively), whereas salbutamol, a ß2-AR agonist, was significantly less efficient in pregnant, compared with nonpregnant, myometrium (Emax = 29 ± 4 vs. 54 ± 8%). Although two populations of binding sites corresponding to ß2- and ß3-AR were identified in both nonpregnant and pregnant myometrium, we found a clear predominance of the ß3-AR subtype. Moreover, ß3-AR binding sites were up-regulated 2-fold in myometrium at the end of pregnancy. Both ß2- and ß3-AR mRNA were expressed in human nonpregnant and pregnant myometrium. Contrary to ß2-AR, the expression of the ß3-AR transcripts and immunoreactive proteins was increased in pregnant, compared with nonpregnant, myometrium. Such compelling data suggest a predominant role for ß3-AR in the regulation of human myometrium contractility, especially at the end of pregnancy, which might have important consequences for the clinical management of preterm labor.
This article has been cited by other articles:
![]() |
F. Lirussi, Z. Rakotoniaina, S. Madani, F. Goirand, M. Breuiller-Fouche, M.-J. Leroy, P. Sagot, J. J. Morrison, M. Dumas, and M. Bardou ADRB3 Adrenergic Receptor Is a Key Regulator of Human Myometrial Apoptosis and Inflammation During Chorioamnionitis Biol Reprod, March 1, 2008; 78(3): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Croci, R. Cecchi, P. Marini, C. Rouget, N. Viviani, G. Germain, F. Guagnini, Y. Fradin, L. Descamps, M. Pascal, et al. In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human beta3-Adrenoceptor Agonist for the Treatment of Preterm Labor J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1118 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rouget, O. Barthez, F. Goirand, M.J. Leroy, M. Breuiller-Fouche, Z. Rakotoniaina, P. Guerard, E.J. Morcillo, C. Advenier, P. Sagot, et al. Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia Biol Reprod, January 1, 2006; 74(1): 209 - 216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |